Accessibility Menu
 
Savara logo

Savara

(NASDAQ) SVRA

Current Price$5.57
Market Cap$1.12B
Since IPO (2017)-38%
5 Year+148%
1 Year+95%
1 Month-7%

Savara Financials at a Glance

Market Cap

$1.12B

Revenue (TTM)

$0.00

Net Income (TTM)

$118.84M

EPS (TTM)

$-0.53

P/E Ratio

-10.22

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$5.57

Volume

31,742

Open

$5.50

Previous Close

$5.57

Daily Range

$5.50 - $5.69

52-Week Range

$1.89 - $7.00

SVRA: Motley Fool Moneyball Superscore

55

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Savara

Industry

Biotechnology

Employees

70

CEO

Matthew Pauls, MBA

Headquarters

Langhorne, TX 78746, US

SVRA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-63%

Return on Capital

-53%

Return on Assets

-47%

Earnings Yield

-9.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.12B

Shares Outstanding

204.66M

Volume

31.74K

Short Interest

0.00%

Avg. Volume

1.67M

Financials (TTM)

Gross Profit

$245.00K

Operating Income

$123.55M

EBITDA

$123.46M

Operating Cash Flow

$101.04M

Capital Expenditure

$22.00K

Free Cash Flow

$101.06M

Cash & ST Invst.

$235.70M

Total Debt

$29.91M

Savara Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$40.00K

+42.9%

Gross Margin

0.00%

N/A

Market Cap

$1.12B

N/A

Market Cap/Employee

$18.94M

N/A

Employees

59

N/A

Net Income

$32.24M

-11.0%

EBITDA

$33.39M

-15.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$205.79M

+21.3%

Accounts Receivable

$1.25M

+20.2%

Inventory

$0.00

N/A

Long Term Debt

$29.91M

+12.4%

Short Term Debt

$7.00K

-94.0%

Return on Assets

-46.89%

N/A

Return on Invested Capital

-53.02%

N/A

Free Cash Flow

$25.06M

-7.7%

Operating Cash Flow

$25.06M

-7.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCAXBicara Therapeutics Inc. Common Stock
$20.50+3.07%
EYPTEyePoint Pharmaceuticals, Inc.
$13.02+1.01%
GERNGeron Corporation
$1.66+11.41%
GHRSGH Research PLC
$14.72+4.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About SVRA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.